Researchers from the University of Gothenburg, in collaboration with colleagues from University of Glasgow, present data that the drug Entresto (sacubitril/valsartan) which is commonly used for the treatment of cardiac failure leads to a marked reduction in plasma Aβ ratio, a candidate blood test for Alzheimer’s disease (AD).
Opinion | Was the FDA Panel Right to Recommend Against MDMA Approval?
Das is an addiction psychiatrist. Untreated mental health concerns remain devastating for our nation, and there is an ongoing need for expanded options and access.